EMEA-001089-PIP02-13-M01

Key facts

Active substance
brodalumab
Therapeutic area
Dermatology
Decision number
P/0189/2018
PIP number
EMEA-001089-PIP02-13-M01
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
Treatment of psoriasis
Route(s) of administration
Subcutaneous use
Contact for public enquiries
LEO Pharma A/S
paediatrics@leo-pharma.com
Denmark
Phone: +45 44945888
Fax: +45 72263321
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating